Kai Pinkernell
Keine laufenden Positionen mehr
Karriereverlauf von Kai Pinkernell
Ehemalige bekannte Positionen von Kai Pinkernell
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Miltenyi GmbH
 Miltenyi GmbH Financial ConglomeratesFinance Miltenyi Biotec GmbH provides biotechnology products and services. The firm products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research. Its clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration and freezing products. The company was founded by Stefan Miltenyi in 1989 and is headquartered in Teterow, Germany. | Corporate Officer/Principal | 01.02.2012 | 01.01.2016 |
| MEDIGENE AG | Chief Tech/Sci/R&D Officer | 12.01.2016 | - |
| PLUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.01.2005 | - |
Ausbildung von Kai Pinkernell
| University of Münster | Doctorate Degree |
| USC Marshall School of Business | Masters Business Admin |
Statistik
International
| Deutschland | 4 |
| Vereinigte Staaten | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Masters Business Admin | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MEDIGENE AG | Health Technology |
| PLUS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Miltenyi GmbH
Miltenyi GmbH Financial ConglomeratesFinance Miltenyi Biotec GmbH provides biotechnology products and services. The firm products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research. Its clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration and freezing products. The company was founded by Stefan Miltenyi in 1989 and is headquartered in Teterow, Germany. | Finance |
- Börse
- Insiders
- Kai Pinkernell
- Erfahrung
